Researchers have used observational data to clarify how the effectiveness of face masks depends on various environmental conditions and has a population-wide impact on the course of the COVID-19 pandemic.

Researchers have proven for the first time that activation of distinct human endogenous retroviruses, which are part of our genome, impair brain development dramatically.

A new iron catalyst helps preferentially reduce nitric oxide, an air pollutant, to hydroxylamine, aiding pollution control and clean energy.

At Technology Networks we understand the importance of time. That's why we've launched Teach Me in 10 a video series that challenges scientists to present and summarize their research area, a scientific concept, or technology in ten minutes or less.

This article discusses the opportunity to use recent advancements in AI and machine learning for natural product drug discovery.

In this op-ed piece, Michael S. Kinch, director of the Centers for Research Innovation in Biotechnology and Drug Discovery at Washington University in St. Louis, explores the issue of eliminating patent protection for COVID-19 vaccines.

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo nonclinical safety evaluation in animal models. This article explores the full process.

As the pandemic enters its second year, the case for optimism has grown shakier. SARS-CoV-2 has been mutating. New variants have arisen in the United Kingdom, Brazil and South Africa, and seem intent on evading our remarkable new vaccines before we’ve even fully rolled them out.

Coupling liquid chromatography (LC) with mass spectrometry (MS) has provided scientists with a powerful tool to meet stringent analytical demands and their versatility and efficiency means LC-MS instruments have become desirable in many laboratories. In this article, we consider how LC-MS works, what it tells us and highlight some of the technique's strengths and weaknesses.